Efficacy and Safety of Celivarone, With Amiodarone as Calibrator, in Patients With an Implantable Cardioverter-Defibrillator for Prevention of Implantable Cardioverter-Defibrillator Interventions or Death

Autor: Kowey, P. R., Crijns, H. J. G. M., Aliot, E. M., Capucci, Kulakowski, Radzik, Roy, Connolly, S. J., Hohnloser, S. H., Singh, B. M., Seltzer, Knight, B. P., Kadish, A. H., Smith, Blaauw, Van, Opstal, Vernooy, Van, Empel, Smid-Ter, Bekke, Guedon, Kouakam, Sadoul, Blangy, Freysz, Mabo, Leclercq, Giniger, Albina, (CI), Padeletti L., (CI), Michelucci A., (CI), Perrotta L., (CI), Pieragnoli P., (CI), Porciani C., (CI), Ricciardi G., Azienda, Universitario Ospedaliera Policlinico Di Careggi, Firenze, (PI), Botto G., (CI), Mariconti B., (CI), Russo G., Azienda Ospedaliera sant’Anna, Como, (PI), Favale S., (CI), Catucci S., (CI), Luzzi G., (CI), Nacci F., (CI), Palmisano P., (CI), Quadrini F., Azienda Ospedaliero Universitaria Policlinico di Bari, (CI), Calò L. (PI) De Ruvo E., (CI), Fagagnini A., Sciarra, L, (CI), Zuccaro L. M., Policlinico, Casilino, Roma, (PI), Mascioli G., (CI), Bakhtadze N., (CI), Belvito C., (CI), Borrelli A., (CI), Lucca E., Istituto Humanitas Gavazzeni, Bergam, O.

Publikováno v: Circulation, 124(24), 2649-U204. LIPPINCOTT WILLIAMS & WILKINS

Background— Celivarone is a new antiarrhythmic agent developed for the treatment of ventricular arrhythmias. This study investigated the efficacy and safety of celivarone in preventing implantable cardioverter-defibrillator (ICD) interventions or d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c922ac97697088ae7000f0fa76cfbd91
https://doi.org/10.1161/circulationaha.111.072561